Skip to main content
QDEL logo

QuidelOrtho Corporation

QDELNASDAQHealthcareMedical Devices

$13.91Today:- (-)1Y −51.06%

As of Oct 15, 2026 close

Market cap
$950.05M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$9.92$35.58
Volume (live)
-
Avg. volume (3M)
1.88M

QuidelOrtho (QDEL) Income Statement

QuidelOrtho reported revenue of $2.73B in fiscal 2025 (fiscal year ended Dec 31, 2025), down 1.9% from $2.78B a year earlier. QuidelOrtho posted a net loss of $1.13B, compared with a net loss of $2.05B a year earlier. Gross margin was 46.7% and operating margin -33.7%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $630.90M, up 2.8% from the same quarter a year earlier.

QuidelOrtho Income Statement Analysis

Values in billions USD

Scroll to see more
QuidelOrtho Corporation income statement - Annual data in billions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2022FY 2021FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Jan 2023Dec 2022Jan 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Revenue & Gross Profit
Revenue2.732.783.003.273.271.701.701.660.530.520.28
Cost of Revenue1.461.501.501.331.330.420.420.310.210.210.12
Gross Profit1.271.291.501.941.941.281.281.350.320.320.16
Operating Expenses
Research & Development0.190.220.250.190.190.100.100.080.050.050.03
Selling, General & Administrative0.750.770.760.620.620.240.240.200.160.150.10
Operating Expenses2.191.241.361.091.090.370.370.290.230.210.13
Operating Income-0.920.050.140.840.840.910.911.060.090.100.01
Other Income/Expense
Interest Income0.000.000.010.000.000.000.000.000.000.000.00
Interest Expense0.180.19-0.18-0.080.070.000.000.000.010.020.02
Other Income/Expense-0.19-1.99-0.17-0.11-0.11-0.01-0.01-0.02-0.02-0.03-0.02
Income
Income Before Tax-1.11-2.13-0.030.740.740.900.901.040.080.06-0.01
Income Tax Expense0.02-0.08-0.020.190.190.200.200.230.00-0.010.00
Net Income-1.13-2.05-0.010.550.550.700.700.810.070.07-0.01
Net Income - Continuous Operations-1.13-2.05-0.01-0.55-0.700.810.070.07-0.01
Net Income - Discontinued Operations-----------
EBITDA-0.49-1.490.711.281.090.970.951.100.140.130.04
EBIT-0.92-1.940.260.990.810.920.90----
Depreciation & Amortization0.440.200.460.280.280.050.050.050.050.050.03
Earnings Per Share
Basic EPS-17.00-30.00-10.0010.0017.0017.0019.002.002.00-
Diluted EPS-17.00-30.00-10.0010.0016.0016.0019.002.002.00-
Basic Shares Outstanding0.070.070.070.060.060.040.040.040.040.040.03
Diluted Shares Outstanding0.070.070.070.060.060.040.040.040.040.040.03

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About QuidelOrtho Financial Statements

What was QuidelOrtho's revenue in fiscal 2025?

QuidelOrtho reported revenue of $2.73B in fiscal 2025 (fiscal year ended Dec 31, 2025). That was down 1.9% from $2.78B a year earlier.

Is QuidelOrtho profitable?

No. QuidelOrtho reported a net loss of $1.13B in fiscal 2025. In fiscal 2024 it lost $2.05B.

What is QuidelOrtho's operating margin?

QuidelOrtho's operating income was −$919.20M on revenue of $2.73B in fiscal 2025, an operating margin of -33.7%, compared with 1.6% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition